These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25491400)

  • 1. Promiscuity and the conformational rearrangement of drug-like molecules: insight from the protein data bank.
    He MW; Lee PS; Sweeney ZK
    ChemMedChem; 2015 Feb; 10(2):238-44. PubMed ID: 25491400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using AutoDock for ligand-receptor docking.
    Morris GM; Huey R; Olson AJ
    Curr Protoc Bioinformatics; 2008 Dec; Chapter 8():Unit 8.14. PubMed ID: 19085980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase inhibition: Ligand binding and conformational change in c-Kit and c-Abl.
    Healy EF; Johnson S; Hauser CR; King PJ
    FEBS Lett; 2009 Sep; 583(17):2899-906. PubMed ID: 19660459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Space-related pharma-motifs for fast search of protein binding motifs and polypharmacological targets.
    Chiu YY; Lin CY; Lin CT; Hsu KC; Chang LZ; Yang JM
    BMC Genomics; 2012; 13 Suppl 7(Suppl 7):S21. PubMed ID: 23281852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced disorder in protein-ligand complexes as a drug-design strategy.
    Crespo A; Fernández A
    Mol Pharm; 2008; 5(3):430-7. PubMed ID: 18278867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein modelling of a novel KIT mutation (N567Y) in the gastrointestinal stromal tumour.
    Alyuruk H; Calibasi G; Cavas L; Baskin Y; Oztop I; Ellidokuz H; Yilmaz U
    Eur J Cancer; 2013 Jul; 49(10):2449-52. PubMed ID: 23588081
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
    Meagher KL; Carlson HA
    J Am Chem Soc; 2004 Oct; 126(41):13276-81. PubMed ID: 15479081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural parameterization of the binding enthalpy of small ligands.
    Luque I; Freire E
    Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs.
    Gallina AM; Bork P; Bordo D
    J Mol Recognit; 2014 Feb; 27(2):65-72. PubMed ID: 24436123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ReFlexIn: a flexible receptor protein-ligand docking scheme evaluated on HIV-1 protease.
    Leis S; Zacharias M
    PLoS One; 2012; 7(10):e48008. PubMed ID: 23110159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty.
    Seeliger MA; Nagar B; Frank F; Cao X; Henderson MN; Kuriyan J
    Structure; 2007 Mar; 15(3):299-311. PubMed ID: 17355866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding.
    Perola E; Charifson PS
    J Med Chem; 2004 May; 47(10):2499-510. PubMed ID: 15115393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: computational approach.
    Rajasekaran R; Sethumadhavan R
    Amino Acids; 2010 Aug; 39(3):651-60. PubMed ID: 20140688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore-based molecular docking to account for ligand flexibility.
    Joseph-McCarthy D; Thomas BE; Belmarsh M; Moustakas D; Alvarez JC
    Proteins; 2003 May; 51(2):172-88. PubMed ID: 12660987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
    Blount KF; Zhao F; Hermann T; Tor Y
    J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scalable and accurate method for classifying protein-ligand binding geometries using a MapReduce approach.
    Estrada T; Zhang B; Cicotti P; Armen RS; Taufer M
    Comput Biol Med; 2012 Jul; 42(7):758-71. PubMed ID: 22658682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo ligand design to an ensemble of protein structures.
    Todorov NP; Buenemann CL; Alberts IL
    Proteins; 2006 Jul; 64(1):43-59. PubMed ID: 16555306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.